WO2005093092A3 - Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44) - Google Patents
Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44) Download PDFInfo
- Publication number
- WO2005093092A3 WO2005093092A3 PCT/EP2005/002600 EP2005002600W WO2005093092A3 WO 2005093092 A3 WO2005093092 A3 WO 2005093092A3 EP 2005002600 W EP2005002600 W EP 2005002600W WO 2005093092 A3 WO2005093092 A3 WO 2005093092A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diseases
- gpr44
- therapeutics
- diagnostics
- diseases associated
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04007435.3 | 2004-03-26 | ||
EP04007435 | 2004-03-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005093092A2 WO2005093092A2 (en) | 2005-10-06 |
WO2005093092A3 true WO2005093092A3 (en) | 2005-11-17 |
Family
ID=34961889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/002600 WO2005093092A2 (en) | 2004-03-26 | 2005-03-11 | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005093092A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015021080A2 (en) | 2013-08-05 | 2015-02-12 | Twist Bioscience Corporation | De novo synthesized gene libraries |
KR20160068802A (en) * | 2013-10-23 | 2016-06-15 | 제넨테크, 인크. | Methods of diagnosing and treating eosinophilic disorders |
US10669304B2 (en) | 2015-02-04 | 2020-06-02 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
TWI726897B (en) * | 2015-07-15 | 2021-05-11 | 日商協和麒麟股份有限公司 | Antibodies that specifically bind to human CRTH2 |
KR20180050411A (en) | 2015-09-18 | 2018-05-14 | 트위스트 바이오사이언스 코포레이션 | Oligonucleotide mutant library and its synthesis |
CN113604546A (en) | 2015-09-22 | 2021-11-05 | 特韦斯特生物科学公司 | Flexible substrates for nucleic acid synthesis |
WO2018057526A2 (en) | 2016-09-21 | 2018-03-29 | Twist Bioscience Corporation | Nucleic acid based data storage |
CA3054303A1 (en) | 2017-02-22 | 2018-08-30 | Twist Bioscience Corporation | Nucleic acid based data storage |
AU2018284227B2 (en) | 2017-06-12 | 2024-05-02 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
CA3075505A1 (en) | 2017-09-11 | 2019-03-14 | Twist Bioscience Corporation | Gpcr binding proteins and synthesis thereof |
SG11202003574TA (en) | 2017-10-20 | 2020-05-28 | Twist Bioscience Corp | Heated nanowells for polynucleotide synthesis |
GB2590196A (en) | 2018-05-18 | 2021-06-23 | Twist Bioscience Corp | Polynucleotides, reagents, and methods for nucleic acid hybridization |
US11492728B2 (en) | 2019-02-26 | 2022-11-08 | Twist Bioscience Corporation | Variant nucleic acid libraries for antibody optimization |
WO2020257612A1 (en) | 2019-06-21 | 2020-12-24 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0851030A1 (en) * | 1996-06-05 | 1998-07-01 | BML Inc. | PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO |
EP1170594A2 (en) * | 2000-07-07 | 2002-01-09 | Pfizer Products Inc. | Methods for the identification of compounds useful for the treatment of disease states mediated by Prostaglandin D2 |
US20020052330A1 (en) * | 1998-02-23 | 2002-05-02 | David Michalovich | Molecular cloning of a chemokine receptor (SBELEVTM) |
US20050038070A1 (en) * | 2003-07-09 | 2005-02-17 | Amgen Inc. | Asthma and allergic inflammation modulators |
-
2005
- 2005-03-11 WO PCT/EP2005/002600 patent/WO2005093092A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0851030A1 (en) * | 1996-06-05 | 1998-07-01 | BML Inc. | PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO |
US20020052330A1 (en) * | 1998-02-23 | 2002-05-02 | David Michalovich | Molecular cloning of a chemokine receptor (SBELEVTM) |
EP1170594A2 (en) * | 2000-07-07 | 2002-01-09 | Pfizer Products Inc. | Methods for the identification of compounds useful for the treatment of disease states mediated by Prostaglandin D2 |
US20020022218A1 (en) * | 2000-07-07 | 2002-02-21 | Baiyong Li | Methods for the identification of compounds useful for the treatment of disease states medicated by prostaglandin D2 |
US20050038070A1 (en) * | 2003-07-09 | 2005-02-17 | Amgen Inc. | Asthma and allergic inflammation modulators |
Also Published As
Publication number | Publication date |
---|---|
WO2005093092A2 (en) | 2005-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005093092A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44) | |
WO2006027147A3 (en) | Diagnostics and therapeutics for diseases associated with adrenomedullin receptor (amdr) | |
WO2005106012A3 (en) | Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (dpp1) | |
WO2005103684A3 (en) | Diagnostics and therapeutics for diseases associated with cx3c chemokine receptor 1 (cx3cr1) | |
WO2006021343A3 (en) | Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine receptor 3a (5-ht3a) | |
WO2005076007A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor p2y12 (p2y12) | |
WO2005093091A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 26 (gpr26) | |
WO2005101001A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor, family c, group 5, member c (gprc5c) | |
WO2005031345A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2) | |
WO2005113786A3 (en) | Diagnostics and therapeutics for diseases associated with chymase (cma1) | |
WO2006005470A3 (en) | Diagnostics and therapeutics for diseases associated with mas related g-protein coupled receptor e (mrge) | |
WO2005073729A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor p2y11 (p2y11) | |
WO2005106486A3 (en) | Diagnostic and therapeutics for diseases associated with dipeptidyl-peptidase 3(dpp3) | |
WO2005108998A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor beta-3 adreno (adrb3) | |
WO2005040211A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 1 (gpr1) | |
WO2005040825A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 20 (gpr20) | |
WO2005113788A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor kinase 6 (grk6) | |
WO2005075983A3 (en) | Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a3 (nr4a3) | |
WO2005059546A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35) | |
WO2004099248A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2) | |
WO2005101009A3 (en) | Diagnostics and therapeutics for diseases associated with tachykinin receptor 2 (tacr2) | |
WO2005100997A3 (en) | Diagnostics and therapeutics for diseases associated with tachykinin receptor 3 (tacr3) | |
WO2005119263A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 92 (gpr92) | |
WO2006024449A3 (en) | Diagnostics and therapeutics for diseases associated with cysteinyl leukotriene receptor 1 (cyslt1) | |
WO2006005461A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 27 (gpr27) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |